Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Oxaliplatin|DRUG: Trastuzumab
Sponsor: Hoosier Cancer Research Network
Collaborators: Sanofi|Hoffmann-La Roche|Walther Cancer Institute